EDAP (EDAP)
Edap Tms S.a.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
EDAP TMS S.A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally.
The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications. This segment also offers Focal One, a HIFU robotic system to treat patients diagnosed with prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL segment manufactures and markets lithotripter for the treatment of urinary tract stones; and provides disposables, replacement parts, and services for lithotripters. This segment also sells spare parts and disposables, such as electrodes. The Distribution segment markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services.
It markets and sells its products through its direct marketing and sales channels, as well as through third-party distributors and agents.
The company serves academic, public, and private hospitals as well as urology clinics. EDAP TMS S.A. was incorporated in 1979 and is based in Vaulx-en-Velin, France.
Leadership
David Horn
Provisionally Appointed Director Subject to Shareholder Ratification
Dr. Lance Willsey
Chairman of the Board
Fran Schulz
Director
François Dietsch
Chief Accounting Officer
Employees
289
Country
FR
Sector
Healthcare
Website
focalone.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| SVP, Marketing & Product Mgmt. | Purchase | 5.0K | $23.8K | Aug 14, 2026 | |
| Director | Purchase | 10.0K | $47.5K | Aug 14, 2026 | |
| Director | Purchase | 10.0K | $47.5K | Aug 14, 2026 | |
| Chief Financial Officer | Purchase | 5.0K | $23.8K | Aug 14, 2026 | |
| Chief Financial Officer | Grant/Award | 144.1K | -- | May 12, 2026 | |
| General Counsel & Corp Sec | Grant/Award | 67.5K | -- | May 12, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
Soleus Capital Management, L.P. | 7.3M | -- | 13F |
AIGH Capital Management LLC · joint filing· may incl. warrants· filed Oct 2026 | 3.5M | 7.6% | 13G |
MORGAN STANLEY | 3.3M | -- | 13F |
Rock Springs Capital Management LP | 1.4M | -- | 13F |
WILLSEY LANCE Director | 1.3M | -- | FORM 4 |
FLAX POND CAPITAL, LLC | 736.2K | -- | 13F |
Rhodes Ryan Chief Executive Officer, Director | 626.6K | -- | FORM 4 |
ESSEX INVESTMENT MANAGEMENT CO LLC | 507.6K | -- | 13F |
Bruce & Co., Inc. | 438.7K | -- | 13F |
Mobeck Kenneth S. Chief Financial Officer | 181.6K | -- | FORM 4 |
Insiders
- Annen StevenSVP, Marketing & Product Mgmt.
- Horn David R.Director
- LEVINE JOSHUADirector
- Mobeck Kenneth S.Chief Financial Officer
- Shah SanketGeneral Counsel & Corp Sec
- Rhodes RyanChief Executive Officer
- WILLSEY LANCEDirector
- Schulz FranDirector
- Dietsch Francois MattieuChief Accounting Officer
30d Avg
--
60d Avg
--
90d Avg
--